Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PMitCEBO vs CHOP in Good Risk Aggressive Non-Hodgkin's Lymphoma
NCT00005867Phase 3Completed
- Sponsor
- Lymphoma Trials Office
- Start
- Jan 1998
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of mitoxantrone, etoposide, bleomycin in non-Hodgkin lymphoma (NHL), sponsored by Lymphoma Trials Office. Started Jan 1998; status: completed.
02
Drugs
mitoxantroneetoposidebleomycin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00005867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005867.